Nasdaq · Healthcare
ALUMIS INC. (ALMS)
As-reported financials and recent SEC filings for ALUMIS INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$24.1M
Net income
$-243.3M
Net margin
—
Diluted EPS
$-2.86
ROE
-80.8%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2024 |
|---|---|---|---|
| Revenue | $24.1M | — | — |
| Gross profit | — | — | — |
| Operating income | $-453.8M | $-300.8M | $-158.2M |
| Net income | $-243.3M | $-294.2M | $-155.0M |
| Diluted EPS | $-2.86 | $-3.46 | $-1.85 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
1442026-07-06
View on EDGAR →42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →8-K2026-07-02
View on EDGAR →SCHEDULE 13D/A2026-07-02
View on EDGAR →Largest Healthcare peers
Go deeper on ALMS
Search ALUMIS INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.